Purdue execs fail to overturn disbarment ruling

A federal district judge has shot down a bid by three former top executives of Purdue Pharma to overturn an order barring them from involvement in any government-financed health care program after they pleaded guilty for fraudulently marketing OxyContin, Barry Meier of the New York Times reports.

Read Watchdog’s prior coverage of the case here.

View the original complaint in the case here.

About Erin Marie Daly

I’m a freelance journalist based in San Francisco. My book on prescription drug and heroin addiction was published in August 2014 by Counterpoint Press.
This entry was posted in Crime, Pharmaceutical Industry and tagged , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *